pharma · Type 2 Diabetes Mellitus · Irritable Bowel Syndrome · LXRX
LEXICON PHARMACEUTICALS
LEXICON PHARMACEUTICALS, INC.
Lexicon Pharmaceuticals is a pharma organization headquartered in The Woodlands, USA. It trades on NYSE under ticker LXRX. Primary therapeutic focus areas include Type 2 Diabetes Mellitus, Irritable Bowel Syndrome, Rheum
8800 Technology Forest, The Woodlands, TX 77381, US HQ
1995 Founded
282 Employees
Public company Type
LXRX · NYSE Ticker
Company details
- Status
- Public
- HQ
- 8800 Technology Forest, The Woodlands, TX 77381, US
- Founded
- 1995
- Employees
- 282
- Programs
- 51
- Drugs
- 27
- Patents
- 102
300 mg LX4211 (150 mg tablets)
Phase 1 · small molecule · Type 2 Diabetes Mellitus
300 mg LX4211 (150 mg tablets) for Type 2 Diabetes Mellitus is a Phase 1 program (small_molecule) at LEXICON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Internal code LX4211.1-102-DM
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- LEXICON PHARMACEUTICALS, INC.
- Phase
- Phase 1
- Modality
- small_molecule
- Indication
- Type 2 Diabetes Mellitus
- Status
- completed
- Trials
- 1